These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23966241)

  • 1. Loss-of-function and gain-of-function mutations of calcium-sensing receptor: functional analysis and the effect of allosteric modulators NPS R-568 and NPS 2143.
    Nakamura A; Hotsubo T; Kobayashi K; Mochizuki H; Ishizu K; Tajima T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1692-701. PubMed ID: 23966241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.
    Rus R; Haag C; Bumke-Vogt C; Bähr V; Mayr B; Möhlig M; Schulze E; Frank-Raue K; Raue F; Schöfl C
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4797-803. PubMed ID: 18796518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of clinically relevant mutations on the pharmacoregulation and signaling bias of the calcium-sensing receptor by positive and negative allosteric modulators.
    Leach K; Wen A; Cook AE; Sexton PM; Conigrave AD; Christopoulos A
    Endocrinology; 2013 Mar; 154(3):1105-16. PubMed ID: 23372019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia.
    D'Souza-Li L; Yang B; Canaff L; Bai M; Hanley DA; Bastepe M; Salisbury SR; Brown EM; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1309-18. PubMed ID: 11889203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional characterization of loss-of-function mutations of the calcium-sensing receptor in four Italian kindreds with familial hypocalciuric hypercalcemia.
    Cetani F; Lemmi M; Cervia D; Borsari S; Cianferotti L; Pardi E; Ambrogini E; Banti C; Brown EM; Bagnoli P; Pinchera A; Marcocci C
    Eur J Endocrinol; 2009 Mar; 160(3):481-9. PubMed ID: 19073830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-sensing receptor sequencing in 21 patients with idiopathic or familial parathyroid disorder: pitfalls and characterization of a novel I32 V loss-of-function mutation.
    Szalat A; Shahar M; Shpitzen S; Nachmias B; Munter G; Gillis D; Durst R; Mevorach D; Leitersdorf E; Meiner V; Rosen H
    Endocrine; 2015 Mar; 48(2):444-53. PubMed ID: 25091521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel mutations of the calcium-sensing receptor gene affecting the same amino acid position lead to opposite phenotypes and reveal the importance of p.N802 on receptor activity.
    Lia-Baldini AS; Magdelaine C; Nizou A; Airault C; Salles JP; Moulin P; Delemer B; Aitouares M; Funalot B; Sturtz F; Lienhardt-Roussie A
    Eur J Endocrinol; 2013 Feb; 168(2):K27-34. PubMed ID: 23169696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
    Babinsky VN; Hannan FM; Gorvin CM; Howles SA; Nesbit MA; Rust N; Hanyaloglu AC; Hu J; Spiegel AM; Thakker RV
    J Biol Chem; 2016 May; 291(20):10876-85. PubMed ID: 26994139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    Bai M; Janicic N; Trivedi S; Quinn SJ; Cole DE; Brown EM; Hendy GN
    J Clin Invest; 1997 Apr; 99(8):1917-25. PubMed ID: 9109436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
    Watanabe S; Fukumoto S
    Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism.
    Hannan FM; Thakker RV
    Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):359-71. PubMed ID: 23856265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations.
    Hendy GN; Canaff L; Newfield RS; Tripto-Shkolnik L; Wong BY; Lee BS; Cole DE
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1311-5. PubMed ID: 24731014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Pidasheva S; D'Souza-Li L; Canaff L; Cole DE; Hendy GN
    Hum Mutat; 2004 Aug; 24(2):107-11. PubMed ID: 15241791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
    Dong B; Endo I; Ohnishi Y; Kondo T; Hasegawa T; Amizuka N; Kiyonari H; Shioi G; Abe M; Fukumoto S; Matsumoto T
    J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.
    Pidasheva S; Canaff L; Simonds WF; Marx SJ; Hendy GN
    Hum Mol Genet; 2005 Jun; 14(12):1679-90. PubMed ID: 15879434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Calcilytic Agent NPS 2143 Rectifies Hypocalcemia in a Mouse Model With an Activating Calcium-Sensing Receptor (CaSR) Mutation: Relevance to Autosomal Dominant Hypocalcemia Type 1 (ADH1).
    Hannan FM; Walls GV; Babinsky VN; Nesbit MA; Kallay E; Hough TA; Fraser WD; Cox RD; Hu J; Spiegel AM; Thakker RV
    Endocrinology; 2015 Sep; 156(9):3114-21. PubMed ID: 26052899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Functional Characterization of a Calcium-Sensing Receptor Mutation in an Infant with Familial Hypocalciuric Hypercalcemia.
    Papadopoulou A; Gole E; Melachroinou K; Meristoudis C; Siahanidou T; Papadimitriou A
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):341-6. PubMed ID: 27087013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel activating mutations of the calcium-sensing receptor: the calcilytic NPS-2143 mitigates excessive signal transduction of mutant receptors.
    Letz S; Rus R; Haag C; Dörr HG; Schnabel D; Möhlig M; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E229-33. PubMed ID: 20668040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study.
    Obermannova B; Sumnik Z; Dusatkova P; Cinek O; Grant M; Lebl J; Hendy GN
    Eur J Endocrinol; 2016 Apr; 174(4):K1-K11. PubMed ID: 26764418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.